Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | Chief Legal Officer | February 08, 2026 | February 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date February 08, 2026 · Filed February 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,605 |
Ending reported balance
After 2026-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-08 · Grant · Acquired 3,198 · Balance 42,753 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2026-02-08 · Tax withholding · Disposed 1,148 · Balance 41,605 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,198 |
Reported balance
After 2026-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-08 · Exercise / conversion · Disposed 3,198 · Balance 3,198 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 1
1 source rowRow 1 · 2022-05-27 · Disposition to issuer · Disposed 708 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $188.95 · Expires 2030-12-01 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-27 · Disposition to issuer · Disposed 2,105 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-27 · Disposition to issuer · Disposed 1,892 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Disposition to issuer · Disposed 6,438 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 714 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 1,420 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 1,260 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 1,559 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 11,910 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 6,439 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 7,256 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 1,020 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 204 · Balance 0 F6: Each restricted stock unit represents the right to receive one share of Quidel common stock. F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F16: 204 shares will vest on January 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F3: 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024.
F4: 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
F5: 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026.
F6: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F7: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F8: 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024.
F9: 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025.
F10: 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025.
F11: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
F12: 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024.
F13: 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026.
F14: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
F15: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F16: 204 shares will vest on January 31, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2026 Filed Feb 10, 2026 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000006 · wk-form4_1770757821.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,198 Underlying: Common Stock · 3,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027. F4 · derivative.expiration_date: 3,197 shares vested on February 8, 2025; 3,198 shares vested on February 8, 2026; and the remaining 3,198 shares will vest on February 8, 2027. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,148 | $29.10 | $33,406.80 |
DisclosureSEC source: 0001833942-26-000006 · wk-form4_1770757821.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,605 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000006 · wk-form4_1770757821.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,753 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 8 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F7 · derivative.exercise_date: 3,628 shares vested on January 31, 2024; and 1,814 shares vested on each of January 31, 2025 and January 31, 2026. F7 · derivative.expiration_date: 3,628 shares vested on January 31, 2024; and 1,814 shares vested on each of January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 7 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 1,610 shares vested on each of January 31, 2024, January 31, 2025 and January 31, 2026. F6 · derivative.expiration_date: 1,610 shares vested on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 651 | $27.17 | $17,687.67 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 4 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,555 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,206 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 578 | $27.17 | $15,704.26 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,392 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,970 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Options · Derivative | 38,561 | $0.00 Strike: $27.17 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 6 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,561 Underlying: Common Stock · 38,561 shares Expires 2036-01-30 F5 · derivative.exercise_date: 12,853 shares will vest on January 30, 2027; the remaining 25,708 shares will vest in equal installments on January 30, 2028 and January 30, 2029. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 19:49 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 38,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000004 · wk-form4_1770166189.xml · derivative · entry 5 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,562 Underlying: Common Stock · 38,562 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 38,562 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. F4 · derivative.expiration_date: 38,562 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:06 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 7,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000002 · wk-form4_1770077187.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,673 Underlying: Common Stock · 7,836 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 7,836 shares vested on January 29, 2026; 7,836 shares will vest on January 29, 2027; and the remaining 7,837 shares will vest on January 29, 2028. F5 · derivative.expiration_date: 7,836 shares vested on January 29, 2026; 7,836 shares will vest on January 29, 2027; and the remaining 7,837 shares will vest on January 29, 2028. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:06 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 3,072 | $27.41 | $84,203.52 |
DisclosureSEC source: 0001833942-26-000002 · wk-form4_1770077187.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,360 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 19:06 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 7,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-26-000002 · wk-form4_1770077187.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,432 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 561 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 16:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-25-000006 · wk-form4_1763673496.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,698 Underlying: Common Stock · 5,349 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 5,349 shares vested on November 18, 2025; the remaining 10,698 shares will vest in equal installments on November 18, 2026 and November 18, 2027. F4 · derivative.expiration_date: 5,349 shares vested on November 18, 2025; the remaining 10,698 shares will vest in equal installments on November 18, 2026 and November 18, 2027. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 16:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 2,717 | $21.28 | $57,817.76 |
DisclosureSEC source: 0001833942-25-000006 · wk-form4_1763673496.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,035 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 16:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-25-000006 · wk-form4_1763673496.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,752 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-25-000005 · wk-form4_1760732072.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 390 shares vested on October 15, 2025. F4 · derivative.expiration_date: 390 shares vested on October 15, 2025. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 199 | $27.31 | $5,434.69 |
DisclosureSEC source: 0001833942-25-000005 · wk-form4_1760732072.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,403 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 16:14 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001833942-25-000005 · wk-form4_1760732072.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,602 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 11,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000142 · wk-form4_1751487052.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,873 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 11,873 shares fully vested on June 30, 2025. F4 · derivative.expiration_date: 11,873 shares fully vested on June 30, 2025. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 6,030 | $28.82 | $173,784.60 |
DisclosureSEC source: 0001906324-25-000142 · wk-form4_1751487052.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,212 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:10 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 11,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000142 · wk-form4_1751487052.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,242 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 25, 2025 Filed May 28, 2025 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000108 · wk-form4_1748463345.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 420 shares vested on May 25, 2025. F4 · derivative.expiration_date: 420 shares vested on May 25, 2025. Read SEC document |
| May 25, 2025 Filed May 28, 2025 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 214 | $29.74 | $6,364.36 |
DisclosureSEC source: 0001906324-25-000108 · wk-form4_1748463345.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,369 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 25, 2025 Filed May 28, 2025 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000108 · wk-form4_1748463345.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,583 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| April 18, 2025 Filed Apr 22, 2025 16:03 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Premium ) · Derivative | 3,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000048 · wk-form4_1745352212.xml · derivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,910 Underlying: Common Stock · 3,910 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units will vest on April 18, 2026. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units will vest on April 18, 2026. Read SEC document |
| April 18, 2025 Filed Apr 22, 2025 16:03 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Converted) · Derivative | 13,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000048 · wk-form4_1745352212.xml · derivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,036 Underlying: Common Stock · 13,036 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.exercise_date: The restricted stock units vested on April 18, 2025. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.expiration_date: The restricted stock units vested on April 18, 2025. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 2,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000040 · wk-form4_1743538615.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,463 Underlying: Common Stock · 2,463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 2,463 shares vested on March 28, 2025; the remaining 2,463 shares will vest on March 28, 2026. F4 · derivative.expiration_date: 2,463 shares vested on March 28, 2025; the remaining 2,463 shares will vest on March 28, 2026. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 882 | $34.89 | $30,772.98 |
DisclosureSEC source: 0001906324-25-000040 · wk-form4_1743538615.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,163 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 2,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000040 · wk-form4_1743538615.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,045 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000027 · wk-form4_1739308537.xml · derivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,396 Underlying: Common Stock · 3,197 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,197 shares vested on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. F4 · derivative.expiration_date: 3,197 shares vested on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 1,144 | $42.89 | $49,066.16 |
DisclosureSEC source: 0001906324-25-000027 · wk-form4_1739308537.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,582 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 16:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 3,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000027 · wk-form4_1739308537.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,726 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · derivative · entry 9 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F7 · derivative.exercise_date: 474 shares vested on January 31, 2025. F7 · derivative.expiration_date: 474 shares vested on January 31, 2025. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 169 | $43.46 | $7,344.74 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 6 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,529 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 5 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,698 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · derivative · entry 8 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,814 Underlying: Common Stock · 1,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 1,814 shares vested on January 31, 2025; the remaining 1,814 shares will vest on January 31, 2026. F6 · derivative.expiration_date: 1,814 shares vested on January 31, 2025; the remaining 1,814 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · derivative · entry 7 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,610 Underlying: Common Stock · 1,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,610 shares vested on January 31, 2025; the remaining 1,610 shares will vest on January 31, 2026. F5 · derivative.expiration_date: 1,610 shares vested on January 31, 2025; the remaining 1,610 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 717 | $43.46 | $31,160.82 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 4 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,224 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 3 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,941 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 662 | $43.46 | $28,770.52 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,127 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000020 · wk-form4_1738703818.xml · nonDerivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,789 F1 · shares: Reflects release of restricted units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 512 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 18:27 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Options · Derivative | 23,508 | $0.00 Strike: $43.52 | $0.00 |
DisclosureSEC source: 0001906324-25-000011 · wk-form4_1738366030.xml · derivative · entry 2 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,508 Underlying: Common Stock · 23,508 shares Expires 2035-01-29 F3 · derivative.exercise_date: 23,508 shares will vest in equal installments on January 29, 2026, January 29, 2027 and January 29, 2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 18:27 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 23,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-25-000011 · wk-form4_1738366030.xml · derivative · entry 1 Hodges Michelle A · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,509 Underlying: Common Stock · 23,509 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 15,672 shares will vest in equal installments on January 29, 2026 and January 29, 2027; the remaining 7,837 shares will vest on January 29, 2028. F2 · derivative.expiration_date: 15,672 shares will vest in equal installments on January 29, 2026 and January 29, 2027; the remaining 7,837 shares will vest on January 29, 2028. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:12 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-24-000067 · wk-form4_1733260355.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 952 shares vested in equal installments on December 1, 2021, December 1, 2022, December 1, 2023 and December 1, 2024. F4 · derivative.expiration_date: 952 shares vested in equal installments on December 1, 2021, December 1, 2022, December 1, 2023 and December 1, 2024. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:12 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Tax withholdingCommon Stock | 85 | $41.00 | $3,485.00 |
DisclosureSEC source: 0001906324-24-000067 · wk-form4_1733260355.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,667 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 16:12 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 238 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-24-000067 · wk-form4_1733260355.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,752 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 16:34 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 16,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-24-000062 · wk-form4_1732138456.xml · derivative · entry 1 Hodges Michelle A. · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,047 Underlying: Common Stock · 16,047 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: 5,349 shares will vest on November 18, 2025, 5,349 shares will vest on November 18, 2026 and 5,349 shares will vest on November 18, 2027. F2 · derivative.expiration_date: 5,349 shares will vest on November 18, 2025, 5,349 shares will vest on November 18, 2026 and 5,349 shares will vest on November 18, 2027. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 20:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001906324-24-000055 · wk-form4_1731460681.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 11,910 shares vested in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. F4 · derivative.expiration_date: 11,910 shares vested in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.